LRIG3 anticorps

N° du produit ABIN2426151

Détail du produit anti-LRIG3 anticorps

Antigène: LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LRIG3 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Purification: Affinity purification

Immunogène: Synthetic peptide of human LRIG3

Isotype: IgG

Information d'application

Indications d'application: IHC 1:25-1:100

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.2 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Conseil sur la manipulation: Avoid freeze / thaw cycles.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur LRIG3

Antigène: LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))

Autre désignation: LRIG3 (LRIG3 Produits)

Synonymes: anticorps LRIG3, anticorps lrig3, anticorps GB17149, anticorps LIG3, anticorps 9030421L11Rik, anticorps 9130004I02Rik, anticorps 9430095K15Rik, anticorps mKIAA3016, anticorps RGD1561255, anticorps leucine rich repeats and immunoglobulin like domains 3, anticorps leucine-rich repeats and immunoglobulin-like domains 3, anticorps leucine-rich repeats and immunoglobulin-like domains protein 3, anticorps leucine-rich repeats and immunoglobulin like domains 3 S homeolog, anticorps leucine-rich repeats and immunoglobulin like domains 3, anticorps LRIG3, anticorps lrig3, anticorps LOC726128, anticorps lrig3.S, anticorps Lrig3

Sujet: Leucine-rich repeats and immunoglobulin-like domains protein 3,Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3,LIG-3,LIG3,LRIG1-3,Lrig3,LRIG3,Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by microarray analysis among genes that show differential expression during gastrulation in Xenopus laevis.Lrig3was expressed in the neural plate and neural crest (NC) at neurula stages, and in NC derivatives and other dorsal structures during tailbud stages. A prominent consequence of the morpholino-induced inhibition ofLrig3expression was impaired NC formation, as revealed by the suppression of marker genes, including Slug, Sox9 and Foxd3.

NCBI Accession: NP_700356